High expression of HLA-E by tumour cells, tumour-associated macrophages and dendritic cells can limit the anti-tumour immune response by NKG2A+ CD8+ tumour-infiltrating lymphocytes [47]. The gene discussed is KLRC1; the disease is neoplasm.